Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Other Working Capital Changes (2016 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Other Working Capital Changes for 15 consecutive years, with -$520000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes fell 42.86% year-over-year to -$520000.0, compared with a TTM value of $529000.0 through Sep 2025, up 28.71%, and an annual FY2024 reading of $505000.0, up 16933.33% over the prior year.
  • Other Working Capital Changes was -$520000.0 for Q3 2025 at Fennec Pharmaceuticals, down from $437000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.9 million in Q1 2024 and bottomed at -$1.7 million in Q2 2024.
  • Average Other Working Capital Changes over 5 years is $1250.0, with a median of -$154500.0 recorded in 2021.
  • The sharpest move saw Other Working Capital Changes tumbled 2866.67% in 2021, then skyrocketed 1560.31% in 2024.
  • Year by year, Other Working Capital Changes stood at -$210000.0 in 2021, then surged by 457.14% to $750000.0 in 2022, then tumbled by 30.67% to $520000.0 in 2023, then rose by 18.08% to $614000.0 in 2024, then plummeted by 184.69% to -$520000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for FENC at -$520000.0 in Q3 2025, $437000.0 in Q2 2025, and -$2000.0 in Q1 2025.